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Background: Pyometra often induces systemic inflammatory response syndrome (SIRS) and early diagnosis is crucial
for survival. Chromogranin A (CgA) is a neuroendocrine secretory protein that is co-released with catecholamines from
the adrenal medulla and sympathetic nerve endings. A prognostic value of CgA has been found in humans that are
critically ill or that have SIRS associated with infection. CgA has not yet been studied in dogs with bacterial infection.
The aim of the study was to investigate CgA, measured by Chromogranin A361-372 (Catestatin; Cst) and Chromogranin
A17-38 (Vasostatin; VS) in healthy dogs and in dogs with pyometra.
Results: Fifty dogs with pyometra, sampled prior to surgery and 64 healthy female dogs were included. In 19
pyometra cases, blood samples were also collected postoperatively. Concentrations of Cst and VS were measured in
heparinised plasma and Cst also measured in EDTA plasma, by in-house radioimmunoassays. Student’s t-test and
Wilcoxon two-sample test was used to test for differences between dog groups. Pre- and postoperative samples in
dogs with pyometra were analysed by paired t-test. Pearson correlation was used to investigate associations of
laboratory variables and hospitalization. P < 0.05 was considered significant.
Concentrations of Cst were decreased in pyometra dogs (mean ± SE, 1.01 ± 0.05 nmol/L) compared to healthy dogs
(mean ± SE, 1.70 ± 0.03 nmol/L) (p ≤ 0.0001). VS concentrations did not differ significantly between dogs with
pyometra (0.40 ± 0.04 nmol/L) and healthy dogs (0.42 ± 0.03 nmol/L). Mean ± SE pre- and postoperative concentration
of Cst (1.0 ± 0.04 nmol/L and 0.9 ± 0.2 nmol/L) and VS (0.36 ± 0.04 nmol/L and 0.36 ± 0.04 nmol/L) in dogs with
pyometra did not differ significantly. Neither Cst nor VS concentrations were associated with duration of hospitalization
and were not significantly different in the four dogs with pyometra that had prolonged (≥3 d) postoperative
hospitalization.
Conclusion: Concentrations of Cst, but not VS, were decreased in pyometra. Cst and VS concentrations before and
after ovariohysterectomy did not differ significantly and were not associated with duration of hospitalization. Further
studies are warranted to evaluate a possible diagnostic or prognostic value for Cst and VS.
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One of the most common diseases of intact female dogs
is bacterial uterine infection and inflammation leading
to pus accumulating in the uterus (pyometra). The dis-
ease induces systemic inflammatory response syndrome
(SIRS) i.e. sepsis in most cases with organ dysfunctions
and death as possible consequences [1]. Early detection
and proper treatment is therefore crucial for survival.
The overall incidence of pyometra is 19% in female dogs
up to 10 years of age, but despite often leading to sepsis,
the mortality rate (3-4%) is relatively low [2-4].
In human medicine, acute phase proteins (APPs)
such as, C-reactive protein (CRP) and Procalcitonin
have been used as biomarkers for diagnostic and prog-
nostic purposes in various diseases [5-9]. Similarly, in
veterinary medicine, biomarkers and APPs are gaining
interest in research studies [10-16]. One of the major
APPs in dogs, CRP, has been shown to increase in dogs
with pyometra [16].
Chromogranin A (CgA) is a neuroendocrine secretory
acidic and water soluble protein, which belongs to the
granin family [17]. It is a prohormone of several func-
tional peptides such as Catestatin and Vasostatin and is
coreleased with catecholamines from the adrenal me-
dulla and sympathetic nerve endings [18,19]. Granins
contain multiple protease and peptidase cleavage sites
and are named based on their biological activities, e.g.
Catestatin, Vasostatin and Pancreastatin [20-23]. Catestatin
(Cst) and Vasostatin (VS), derived from CgA are known
to act as cardio-protectants in case of ischaemic/reper-
fusion injury [24,25]. Several studies have shown that
concentrations of stress-related neurochemicals, e.g. cate-
cholamines that are released together with CgA, increase
in sepsis [26-29].
Measurement of CgA is useful for diagnostic and
predictive purposes in various syndromes and dis-
eases in humans such as sepsis, neuroendocrine tu-
mors and heart disease [30-34]. Moreover, increased
CgA concentration has prognostic value in human
patients suffering from stress, critical illness or infec-
tion associated with SIRS [30-32]. So far, concentra-
tions of CgA have not been investigated in dogs with
infection or before and after surgery. Because measure-
ments of intact CgA are not possible yet in dogs, measure-
ments of Cst and VS concentrations using in-house
methods that have been validated for use in this species
were applied [35].
The aims of the present study were to investigate con-
centrations of CgA, measured by Cst and VS, in healthy
dogs and in dogs with pyometra, and before and after
surgery to evaluate a possible diagnostic or prognostic
value. CRP, hospitalization and laboratory variables were
also investigated to evaluate whether they were associ-
ated with either Cst or VS.Methods
Ethical approval
The study was approved by the Uppsala Local Ethical
Board (permission number C413/12), and a written in-
formed owner consent was obtained before inclusion in
the study.
Animals
In total, 114 female dogs were included in the study. Of
these, 50 were bitches with pyometra (23 breeds) and 64
were healthy dogs (22 breeds) (for more details on the
included breeds see Additional file 1). A complete phys-
ical examination was performed by the veterinarian in
charge, and the results recorded in a special form and in
the patient records. The preliminary diagnosis of pyome-
tra was based on case history data, findings on physical
examination, laboratory test results, and diagnostic im-
aging by either abdominal ultrasonography or radiology
or both. All bitches with pyometra were treated by ovario-
hysterectomy (OHE) at the University Animal Hospital
(UDS), Swedish University of Agricultural Sciences (SLU),
Uppsala, during the study period 2009–2013.
The diagnosis pyometra was confirmed by postopera-
tive macroscopic identification of a pus-filled uterus to-
gether with histopathological diagnosis and/or positive
bacterial culture from the uterine content. Histopatho-
logical examination of formaldehyde-fixed uteri and
ovaries was performed at the Department of Biomedical
Sciences and Veterinary Public Health, SLU, Uppsala.
Samples for bacterial identification and drug sensitivity
were immediately collected from uterine content by using
sterile fibre cotton swabs (Culturette; Becton-Dickinson
AG, Stockholm, Sweden). The methods were performed
at the accredited laboratory, Section of Bacteriology,
National Veterinary Institute (SVA), Uppsala, Sweden as
earlier described [36]. Dogs diagnosed with Mucometra,
Hydrometra, Cystic endometrial hyperplasia (CEH) or
uterine tumours were excluded. Prolonged postoperative
hospitalization was defined as ≥ 3 days, as described in
our previous study (regular postoperative hospitalization
after OHE at UDS is 1–2 days) [16].
Blood sampling and laboratory tests
Hematological and biochemical analysis
Blood was obtained from dogs with pyometra immedi-
ately or up to two hours before surgery and from the
healthy control dogs. From 19 of the 50 dogs with pyo-
metra, blood samples were collected both prior to and
24 ± 3 h after surgery. The samples were aseptically
collected from the distal cephalic vein into heparinised,
EDTA and nonadditive collection tubes (Vacutainer®,
Becton-Dickinson, Stockholm, Sweden). Hematological
analyses (Total white blood cell count (WBC), including
differential counts, Hematocrit (PCV) and Hemoglobin
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Diagnostics, Deerfield, IL, USA). After centrifugation
and separation of serum and plasma, biochemical and
CRP analyses- Albumin, Bile acids, Alanine aminotrans-
ferase (ALT), Glucose, Blood urea nitrogen (BUN), and
Creatinine- were performed (Abbott Archtect c4000,
Abbott Park, IL, USA). All analyses were conducted ac-
cording to routine methods at the Clinical Pathology
Laboratory, UDS, SLU, Uppsala, Sweden. Unused serum
and plasma was transferred in aliquots of 200 μL into
cryogenic vials (NuncCryoTubes, VWR International,
Stockholm, Sweden), and freeze-stored at −80°C until
analysis of CgA.
Biomarker analyses
CRP was analysed by an automated assay (High Linearity
CRP, Randox Laboratories, Crumlin, United Kingdom)
performed on Abbot Architect (Abbott Architect c4000,
Abbott Park, IL, USA). The method has previously been
validated for dogs [37,38]. The limit of quantification
was 5 mg/L with a mean intra- and interassay variation
of 1.4% and 2.4%, respectively. Samples with concentra-
tions of CRP- above 217 and 225 mg/L for the two lots
used- were autodiluted 1:3 with 0.9% NaCl and reana-
lysed to obtain exact values.
Cst and VS were measured in heparinised plasma by
radioimmunoassays specific for Cts and VS [39,40] and
previous validated for use in dogs [35]. None of the
commercial methods to determine CgA can be used for
measurements in dogs (and other animals), due to the
large differences in amino acid sequences between differ-
ent species. However, defined parts of the CgA molecule
have higher amino acid homology and methods that are
specific to these parts can be used to measure CgA in
several animal species, including dogs [35,39]. This
cross-reactivity was first shown in a study using the
same VS assay as in our study for measurements of CgA
in the human, bovine, equine, porcine and ovine species
[39]. Other parts of the CgA molecule have been investi-
gated for potential cross reactivity and it was found that
both VS and Cst could also be used in dogs [35]. These
assays are described in detail in a previous study and are
in-house assays performed at the Research Department
of Clinical Chemistry, Uppsala University Hospital,
Sweden [40]. Furthermore, it has been shown that there
is a positive correlation between VS and intact CgA,
which justifies the use of VS to estimate CgA concentra-
tions [39,40]. For Catestatin, there is a cross reactivity
that allows us to use also this part of the CgA molecule
to estimate of CgA concentrations [35].
The validation study of CgA in dogs and cats was per-
formed by using extracts of CgA from the adrenal gland
since it contains high concentrations of CgA [35]. The
coefficient of variation (CV) was 3.6% for Cst and 8.8%for VS. To test preanalytical conditions, analysis of Cst
was performed in both EDTA and heparinised plasma
from 45 dogs with pyometra.
Statistical analyses
Statistical analyses were performed by using Minitab
software programs for Windows version 16 (Minitab
Inc., State College, PA, USA). The Anderson-Darling test
was used to evaluate normality of data distribution. For
normally distributed data, Student’s t-test was used to
test differences of hematology, biochemistry, Cst and VS
variable between dogs with pyometra and healthy dogs.
Concentrations of Cst and VS in pre- and postoperative
samples in the pyometra group were compared by using
paired t-tests. In the healthy dogs that had concentra-
tions of CRP lower than 5 mg/L, the concentration was
set to half the limit of quantification (2.5 mg/L) for the
statistical analyses. A Wilcoxon two-sample test was used
for analysis when most healthy dogs had CRP concentra-
tions below the lower measurable concentration. In the
dogs with pyometra, Pearson’s correlation was used to
evaluate associations between Cst and VS and other vari-
ables - including age, weight, hematology, biochemistry,
CRP, and duration of hospitalization. Pearson’s correlation
was used to investigate associations between Cst and VS
in heparinised and EDTA plasma. The significance level
was set at p < 0.05 for all tests used.
Results
Dogs
The mean age (± SD) was significantly higher in the pyo-
metra group (7.2 ± 2.5 years, n = 49) compared to the
control group (5.4 ± 3.5 years, n = 54, p = 0.003). The
mean weight (± SD) was significantly higher in the dogs
with pyometra (27.5 ± 9.5 kg, n = 50) compared to the
healthy dogs (21.6 ± 9.4, n = 64, p = 0.001). Neither Cst
nor VS concentrations were correlated to age or weight
in the healthy dogs.
Laboratory variables
In the pyometra group, WBC, Neutrophils, Band neutro-
phils and Monocyte were increased compared to the
control group. Meanwhile, Hb, PCV, Lymphocytes and
Albumin were significantly decreased in dogs with pyo-
metra compared to healthy group (Table 1). Most dogs
in the pyometra group had Creatinine and BUN concen-
trations within the reference range for healthy dogs
(Table 1).
Biomarkers
Concentrations of Cst were significantly decreased in
dogs with pyometra compared to healthy dogs (Table 2).
VS concentrations did not differ between the two groups
of dogs (Table 2). CRP concentrations were significantly
Table 1 Hematology and biochemistry variables in 50 dogs with pyometra (pyometra group) and 64 healthy dogs
(control group)
Variable Pyometra group Control group p value Reference
range†Mean ± SE (n) (range) Mean ± SE (n) (range) (student’s t-test)
Hemoglobin (g/L) 131 ± 4 (47) 159 ± 3 (48) <0.0001 132 - 199
(89 - 192) (111 - 203)
Hematocrit (PCV) (%) 37 ± 1 (47) 45 ± 0 (48) <0.0001 38 - 57
(25 - 53) (32 - 59)
WBC (x109/L) 19.7 ± 2.2 (48) 9.3 ± 0.3 (56) <0.0001 5.8 - 16.0
(4.9 - 106.4) (4.5 - 16.6)
Neutrophils (x109/L) 11.9 ± 1.8 (46) 5.5 ± 0.2 (56) 0.001 3.0 - 11.5
(0.1 - 85.1) (1.1 - 10.7)
Band neutrophils (x109/L) 4.0 ± 0.8 (44) 0.4 ± 0.2 (42) <0.0001 0 - 0.3
(0 - 22.4) (0 - 9.0)
Lymphocytes (x109/L) 1.7 ± 0.1 (46) 2.3 ± 0.1 (56) 0.005 1.4 - 4.8
(0 - 4.4) (0.5 - 5.1)
Monocytes (x109/L) 1.8 ± 0.2 (46) 0.7 ± 0.2 (56) <0.0001 0.2 - 1.4
(0.2 - 5.4) (0 - 9.2)
Eosinophils (x109/L) 0.4 ± 0.1 (45) 0.8 ± 0.1 (56) 0.02 0.1 - 1.2
(0 - 3.6) (0 - 4.4)
Basophils (x109/L) 0 ± 0 (45) 0.05 ± 0.02 (56) 0.06 0 - 0.1
(0 - 0.3) (0 - 1.0)
Albumin (g/L) 26.2 ± 0.7 (43) 30.0 ± 0.4 (46) <0.0001 29 - 39
(18 - 35) (22 - 34)
Bile acids (μmol/L) 3.4 ± 0.6 (42) 9.9 ± 2.5 (41) 0.01 0 - 12
(0.3 - 17.3) (0 - 63.5)
ALT (μkat/L) 0.5 ± 0.09 (45) 0.6 ± 0.03 (52) 0.66 0 - 1.3
(0 - 3.9) (0.1 - 1.3)
Glucose (mmol/L) 5.0 ± 0.18 (42) 5.1 ± 0.1 (41) 0.4 4.5 - 5.8
(1.5 - 7.3) (3.7 - 6.8)
BUN (mmol/L) 3.7 ± 0.2 (43) 5.5 ± 0.3 (41) <0.0001 2.5 - 8.8
(1.5 - 7.5) (3.0 - 14)
Creatinine (μmol/L) 65.7 ± 3.1 (43) 72 ± 2 (43) 0.2 40 - 130
(43 - 155) (50 - 96)
WBC = Total white blood cell count, ALT = Alanine aminotransferase, BUN = Blood urea nitrogen.
†Reference range (at the Clinical Pathology Laboratory, University Animal Hospital, Swedish University of Agricultural Sciences, Uppsala).
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group (Table 2). Concentrations of Cst and VS were
moderately positively correlated (rp = 0.3, p = 0.03).
Cst concentrations were moderately positively corre-
lated with Hb and PCV in the pyometra group (rp = 0.3,
p = 0.03 and rp = 0.3, p = 0.03, respectively).
CRP concentrations were not correlated with Cst or
VS in the pyometra group.
Cst and VS concentrations in dogs with pyometra
before and 24 ± 3 h after surgery did not differ signifi-
cantly (Table 3). Cst concentrations prior to surgery in
the dogs with pyometra with prolonged postoperativehospitalization (n = 4) did not differ significantly from
those with regular postoperative hospitalization (≤ 2
days, n = 15, mean ± SE, 0.91 ± 0.07 nmol/L and 0.82 ±
0.24 nmol/L, respectively). VS concentrations before
surgery did not differ significantly between bitches
with prolonged hospitalization and bitches with regu-
lar postoperative hospitalization (mean ± SE concen-
tration, 0. 57 ± 0.14 nmol/L and 0.32 ± 0.03 nmol/L,
respectively).
Cst and VS concentrations in heparinised plasma
and EDTA plasma were strongly positively correlated
(rp = 0.825, p < 0.001).
Table 2 Concentrations of Catestatin (Cst) and Vasostatin
(VS), and C-reactive protein (CRP) in 50 dogs with
pyometra (Pyometra group) and 64 healthy female
dogs (control group)
Variable Pyometra group Control group p value
Mean ± SE (n) (range) Mean ± SE (n) (range)
Cst 1.0 ± 0.05 (50) 1.7 ± 0.03 (64) <0.0001*
(nmol/L) (0.10 - 1.66) (1.07 - 2.3)
VS 0.40 ± 0.04 (48) 0.42 ± 0.30 (64) 0.7
(nmol/L) (0.14 - 1.34) (0.10 - 1.34)
CRP 174.9 ± 20.7 (35) <4.5 ± 1.4 (21) 0.001¶
(mg/L) (2.5 - 370) (2.5 - 28)
*p value = Student’s t-test, ¶p value = Wilcoxon two sample test.
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Concentrations of plasma Cst were decreased in dogs
with pyometra. This result was somewhat unexpected, as
it is not in line with increased CgA blood concentrations
found in critically ill and intensive care human patients
with severe sepsis and other diseases [30-32,41]. Most
studies in humans include patients investigated during
early stages of disease, but in pyometra, the disease may
have developed during several days or weeks before ad-
mission to an animal hospital, which could explain the
decreased levels of Cst in dogs with pyometra.
Another explanation for the lower concentrations
found in dogs with pyometra could be that negative
feedback control of Cst leads to inhibited secretion of
catecholamines and CgA, and subsequently decreased
CgA concentrations. Several studies in humans have re-
ported that Cst is a potent and specific cholinergic antag-
onist in chromaffin cells, and increased Cst concentration
could thereby inhibit catecholamine secretion [23,42].
Such negative feedback would be more likely to occur in
individuals with chronic (pyometra) as opposed to acute
disease (severe illness or sepsis in the studied human
patients).
Inflammation and sepsis may lead to impaired coagu-
lation [43] and has been shown to occur in bitches suf-
fering from pyometra [44]. Disturbed coagulation hasTable 3 Concentrations of of Catestatin (Cst) and Vasostatin
(VS) in 19 dogs with pyometra sampled before surgery
(preoperative) and after surgery (postoperative)
Variable Preoperative Postoperative p value
Mean ± SE (n)
(range)




Cst 0.89 ± 0.07 (19) 0.86 ± 0.04 (19) 0.6
(nmol/L) (0.10 - 1.28) (0.61 - 1.21)
VS 0.36 ± 0.04 (18) 0.36 ± 0.04 (18) 0.9
(nmol/L) (0.16 - 0.95) (0.1 - 0.73)previously been reported as one of many pathologies in
dogs with the disease [44]. This may be because the
inflammatory response induced in pyometra is multifa-
ceted. A study on gene activation in the uterine tissue in
dogs with pyometra found over 800 upregulated genes
including genes encoding proteinases, proteolyses, disin-
tegrin and metalloproteinase with thrombospondin type
1-like motifs (ADAMTS) families and thrombospondin-4
regulating gene [45]. In a study in humans, thrombin
caused decreased CgA concentrations in the circulation
and it was also shown that several proteinases were in-
volved in this process [46]. These findings indicate that
thrombin could play a role in causing decreased Cst con-
centrations. However, mechanisms and interrelationship
of CgA, thrombin and severe illness have not yet been
studied in detail in dogs.
Possibly there is a system for downregulation of CgA
in response to infection, at least in some animal species.
Because this is the first report of CgA in a disease re-
lated to sepsis in dogs, the diagnostic and predictive
value of CgA needs to be further studied for such evalu-
ation to be possible. In critically ill human patients,
serum CgA concentrations were correlated with concen-
trations of serum creatinine [32]. In the present study,
no such correlation could be found, possibly because
most diseased dogs studied here had creatinine concen-
trations within the normal reference range for healthy
dogs. Cst and VS concentrations were correlated, albeit
not strongly but VS concentrations did not differ signifi-
cantly between the pyometra group and the control
group. This finding is in contrast to results in humans
where increased VS blood concentrations were related
to sepsis and survival [47,48]. Differences in results
among studies may be due to interspecies variation or
because the dogs included in our study suffered from
less severe disease compared to the studied humans.
Why Cst concentrations but not VS concentrations
were decreased remains to be determined. The relation
between intact CgA and its fragments is complex and al-
though this has not been shown, one possible explan-
ation of the demonstrated differences found between Cst
and VS could be that Cst measurement comprises both
intact CgA and Cst as well as other possible fragments
of CgA that contain the Cst part. Because the assay is
expressed in molar units it measures the number of mol-
ecules present in the sample i.e. the assay most probably
measures the total CgA content. The same is true for VS
measurements with the currently used assay, but when
comparing results from these two assays (Cst and VS),
diverging results were found. As mentioned earlier, Cst
and VS have different biological activities which could
also partly explain this divergence [49-54]. The metabolic
clearance rate of the two molecules may likewise differ,
which in turn can influence the number of molecules that
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that could explain the resulting two different CgA levels
measured by the Cst and VS assays.
The concentration of Cst in healthy dogs, using the
same method as used here, was lower in a study of fe-
male and male Beagle dogs [55]. It is possible that CgA
concentrations vary by breed, which could explain why
the results of the present study, including results from
many breeds, differed from the study that included only
dogs of one breed (Beagle). Further, in a study in humans,
it was reported that gender influenced the concentration
of CgA in plasma [56]. Our study included only female
dogs while the previous study included both genders and
this may also have contributed to the differences in CgA
concentrations between the present and the earlier report
in dogs [55].
Measuring concentrations of the entire CgA molecule
in dogs would give more accurate information of CgA
compared to measuring Cst and VS, but currently such
a method is not available. For more knowledge and un-
derstanding of mechanisms and roles of CgA in dogs
with infection, further studies are necessary.
That CRP concentrations were increased in pyometra
is in accordance with findings of several other studies,
and is a consequence of the severe inflammatory response
induced [15,16,57]. CRP was, however, not correlated with
CgA (Cst or VS) and the CgA concentrations measured
before surgery did not differ from concentrations mea-
sured after surgery in spite of a possible response to sur-
gery. Additionally, the length of hospitalization was not
associated with the concentrations of Cst or VS. These
results are in contrast to a study in humans with sepsis
which found that more severe systemic inflammation,
indicated by higher CRP, was linked with higher concen-
trations of CgA and that survivors had a lower CgA
concentrations compared to nonsurvivors [32]. The rea-
son for the lack of association between CgA and CRP or
postoperative hospitalization (as a measurement indicator
of morbidity) is unknown, and an association between
CgA and mortality remains to be investigated because no
dogs died of the pyometra in current study.
In pyometra, the PCV, Hb, Lymphocyte and Albumin
concentrations were decreased whereas WBC, Neutrophils,
Band neutrophils, and Monocytes were increased in dogs
with pyometra compared to healthy dogs. These results
illustrate the systemic illness induced by the disease,
and shows that the dogs studied were indeed severely
affected [4].
CgA in heparinised plasma was strongly positively cor-
related with CgA in EDTA plasma. These results show
that both heparinised and EDTA plasma can be used for
Cst analysis in dogs.
A limitation of the study was that some the samples
had been freeze-stored up to 5 years before analysis ofCst and VS. This duration however is unlikely to have
affected the results as samples from both groups were
collected during the same time period and CgA is stable
at room temperature and minimally affected by repeated
thawing-refreezing cycles [58]. CRP is also considered
stable in room temperature and when freeze stored [59].
That age and weight differences between the two study
groups could have somewhat influenced the results can-
not be completely excluded, but because the age and
weight were not correlated with CgA, as tested in the 64
healthy bitches, a notable effect on the results presented
here is not expected.
It has been shown that Cst is upregulated in skin during
bacterial infection [60], but whether local infection of the
uterus has any effect on Cst has not yet been investigated.
Based on the present results, it could be speculated that
CgA is more likely to be released in response to systemic
inflammation as it did not decrease after surgical removal
of the infected uterine tissue. However, Cst might still be
clinically valuable if used together with other markers for
diagnostic and prognostic purposes in dogs with severe ill-
ness induced by pyometra. The value of CgA and its prod-
ucts when measured in dogs with sepsis remains to be
determined.
Conclusion
CgA concentrations were decreased in pyometra, as mea-
sured by Cst. Concentrations of VS and Cst were corre-
lated but VS concentrations did not differ between the
diseased and healthy groups of dogs studied. None of
studied variables had predictive value for prognosis as
measured by correlation with postoperative hospitalization
or when compared between dogs with prolonged and nor-
mal hospitalization. Further studies are needed to investi-
gate whether Cst or VS derived of CgA are related to
severity or mortality.
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